APO Research
Talk to an analyst

APO RESEARCH · REPORT

Comprehensive Solution for Molecular Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Comprehensive Solution for Molecular Testing Market Outlook and Growth Opportunities 2026

5 March 2026195 pages

Choose your research edition.

Industry ResearchComprehensive Solution for Molecular Testing Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Comprehensive Solution for Molecular Testing Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Comprehensive Solution for Molecular Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Comprehensive Solution for Molecular Testing Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Comprehensive Solution for Molecular Testing Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Comprehensive Solution for Molecular Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Comprehensive Solution for Molecular Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Comprehensive Solution for Molecular Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Comprehensive Solution for Molecular Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Comprehensive Solution for Molecular Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Comprehensive Solution for Molecular Testing market include Roche Diagnostics, Thermo Fisher Scientific, Qiagen, Illumina, Bio-Rad Laboratories, Cepheid, BD, GenMark Diagnostics and Hologic, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Comprehensive Solution for Molecular Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Comprehensive Solution for Molecular Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Comprehensive Solution for Molecular Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Comprehensive Solution for Molecular Testing market.

Comprehensive Solution for Molecular Testing Segment by Company

Roche Diagnostics

Thermo Fisher Scientific

Qiagen

Illumina

Bio-Rad Laboratories

Cepheid

BD

GenMark Diagnostics

Hologic

PerkinElmer

Hanchenguangyi Technology

Shenzhen Guangyu Biotechnology

Hangzhou Leyi Biotechnology

Flashdx

VivaChek Biotech

Comprehensive Solution for Molecular Testing Segment by Type

Nucleic Acid Amplification Testing

Protein Detection

Metabolite Detection

Others

Comprehensive Solution for Molecular Testing Segment by Application

Hospital

Research Institute

Others

Comprehensive Solution for Molecular Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Comprehensive Solution for Molecular Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Comprehensive Solution for Molecular Testing key companies, revenue, market share, and recent developments.

3. To split the Comprehensive Solution for Molecular Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Comprehensive Solution for Molecular Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Comprehensive Solution for Molecular Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Comprehensive Solution for Molecular Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Comprehensive Solution for Molecular Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Comprehensive Solution for Molecular Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Comprehensive Solution for Molecular Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Comprehensive Solution for Molecular Testing industry.

Chapter 3: Detailed analysis of Comprehensive Solution for Molecular Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Comprehensive Solution for Molecular Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Comprehensive Solution for Molecular Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Comprehensive Solution for Molecular Testing Industry Trends Table 2. Comprehensive Solution for Molecular Testing Industry Drivers Table 3. Comprehensive Solution for Molecular Testing Industry Opportunities and Challenges Table 4. Comprehensive Solution for Molecular Testing Industry Restraints Table 5. Global Comprehensive Solution for Molecular Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Comprehensive Solution for Molecular Testing Revenue Share by Company (2021-2026) Table 7. Global Comprehensive Solution for Molecular Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Comprehensive Solution for Molecular Testing Key Company Manufacturing Base & Headquarters Table 9. Global Comprehensive Solution for Molecular Testing Company, Product Type & Application Table 10. Global Comprehensive Solution for Molecular Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Comprehensive Solution for Molecular Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Nucleic Acid Amplification Testing Table 15. Significant Companies of Protein Detection Table 16. Significant Companies of Metabolite Detection Table 17. Significant Companies of Others Table 18. Global Comprehensive Solution for Molecular Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Comprehensive Solution for Molecular Testing Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Comprehensive Solution for Molecular Testing Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Comprehensive Solution for Molecular Testing Sales Value Share by Type (2021-2026) Table 22. Global Comprehensive Solution for Molecular Testing Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Table 24. Significant Companies of Research Institute Table 25. Significant Companies of Others Table 26. Global Comprehensive Solution for Molecular Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Comprehensive Solution for Molecular Testing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Comprehensive Solution for Molecular Testing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Comprehensive Solution for Molecular Testing Sales Value Share by Application (2021-2026) Table 30. Global Comprehensive Solution for Molecular Testing Sales Value Share by Application (2027-2032) Table 31. Global Comprehensive Solution for Molecular Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Comprehensive Solution for Molecular Testing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Comprehensive Solution for Molecular Testing Sales Value Share by Region (2021-2026) Table 34. Global Comprehensive Solution for Molecular Testing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Comprehensive Solution for Molecular Testing Sales Value Share by Region (2027-2032) Table 36. Global Comprehensive Solution for Molecular Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Comprehensive Solution for Molecular Testing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Comprehensive Solution for Molecular Testing Sales Value Market Share by Country (2021-2026) Table 39. Global Comprehensive Solution for Molecular Testing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Comprehensive Solution for Molecular Testing Sales Value Market Share by Country (2027-2032) Table 41. Roche Diagnostics Company Information Table 42. Roche Diagnostics Business Overview Table 43. Roche Diagnostics Comprehensive Solution for Molecular Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Roche Diagnostics Comprehensive Solution for Molecular Testing Product Portfolio Table 45. Roche Diagnostics Recent Development Table 46. Thermo Fisher Scientific Company Information Table 47. Thermo Fisher Scientific Business Overview Table 48. Thermo Fisher Scientific Comprehensive Solution for Molecular Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Thermo Fisher Scientific Comprehensive Solution for Molecular Testing Product Portfolio Table 50. Thermo Fisher Scientific Recent Development Table 51. Qiagen Company Information Table 52. Qiagen Business Overview Table 53. Qiagen Comprehensive Solution for Molecular Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Qiagen Comprehensive Solution for Molecular Testing Product Portfolio Table 55. Qiagen Recent Development Table 56. Illumina Company Information Table 57. Illumina Business Overview Table 58. Illumina Comprehensive Solution for Molecular Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Illumina Comprehensive Solution for Molecular Testing Product Portfolio Table 60. Illumina Recent Development Table 61. Bio-Rad Laboratories Company Information Table 62. Bio-Rad Laboratories Business Overview Table 63. Bio-Rad Laboratories Comprehensive Solution for Molecular Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Bio-Rad Laboratories Comprehensive Solution for Molecular Testing Product Portfolio Table 65. Bio-Rad Laboratories Recent Development Table 66. Cepheid Company Information Table 67. Cepheid Business Overview Table 68. Cepheid Comprehensive Solution for Molecular Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Cepheid Comprehensive Solution for Molecular Testing Product Portfolio Table 70. Cepheid Recent Development Table 71. BD Company Information Table 72. BD Business Overview Table 73. BD Comprehensive Solution for Molecular Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. BD Comprehensive Solution for Molecular Testing Product Portfolio Table 75. BD Recent Development Table 76. GenMark Diagnostics Company Information Table 77. GenMark Diagnostics Business Overview Table 78. GenMark Diagnostics Comprehensive Solution for Molecular Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. GenMark Diagnostics Comprehensive Solution for Molecular Testing Product Portfolio Table 80. GenMark Diagnostics Recent Development Table 81. Hologic Company Information Table 82. Hologic Business Overview Table 83. Hologic Comprehensive Solution for Molecular Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Hologic Comprehensive Solution for Molecular Testing Product Portfolio Table 85. Hologic Recent Development Table 86. PerkinElmer Company Information Table 87. PerkinElmer Business Overview Table 88. PerkinElmer Comprehensive Solution for Molecular Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. PerkinElmer Comprehensive Solution for Molecular Testing Product Portfolio Table 90. PerkinElmer Recent Development Table 91. Hanchenguangyi Technology Company Information Table 92. Hanchenguangyi Technology Business Overview Table 93. Hanchenguangyi Technology Comprehensive Solution for Molecular Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Hanchenguangyi Technology Comprehensive Solution for Molecular Testing Product Portfolio Table 95. Hanchenguangyi Technology Recent Development Table 96. Shenzhen Guangyu Biotechnology Company Information Table 97. Shenzhen Guangyu Biotechnology Business Overview Table 98. Shenzhen Guangyu Biotechnology Comprehensive Solution for Molecular Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Shenzhen Guangyu Biotechnology Comprehensive Solution for Molecular Testing Product Portfolio Table 100. Shenzhen Guangyu Biotechnology Recent Development Table 101. Hangzhou Leyi Biotechnology Company Information Table 102. Hangzhou Leyi Biotechnology Business Overview Table 103. Hangzhou Leyi Biotechnology Comprehensive Solution for Molecular Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Hangzhou Leyi Biotechnology Comprehensive Solution for Molecular Testing Product Portfolio Table 105. Hangzhou Leyi Biotechnology Recent Development Table 106. Flashdx Company Information Table 107. Flashdx Business Overview Table 108. Flashdx Comprehensive Solution for Molecular Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Flashdx Comprehensive Solution for Molecular Testing Product Portfolio Table 110. Flashdx Recent Development Table 111. VivaChek Biotech Company Information Table 112. VivaChek Biotech Business Overview Table 113. VivaChek Biotech Comprehensive Solution for Molecular Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. VivaChek Biotech Comprehensive Solution for Molecular Testing Product Portfolio Table 115. VivaChek Biotech Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Comprehensive Solution for Molecular Testing Product Image Figure 2. Global Comprehensive Solution for Molecular Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Comprehensive Solution for Molecular Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Comprehensive Solution for Molecular Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Nucleic Acid Amplification Testing Image Figure 8. Protein Detection Image Figure 9. Metabolite Detection Image Figure 10. Others Image Figure 11. Global Comprehensive Solution for Molecular Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Comprehensive Solution for Molecular Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Comprehensive Solution for Molecular Testing Sales Value Share by Type (2021-2032) Figure 14. Hospital Image Figure 15. Research Institute Image Figure 16. Others Image Figure 17. Global Comprehensive Solution for Molecular Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Comprehensive Solution for Molecular Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Comprehensive Solution for Molecular Testing Sales Value Share by Application (2021-2032) Figure 20. Global Comprehensive Solution for Molecular Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Comprehensive Solution for Molecular Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Comprehensive Solution for Molecular Testing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Comprehensive Solution for Molecular Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Comprehensive Solution for Molecular Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Comprehensive Solution for Molecular Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Comprehensive Solution for Molecular Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Comprehensive Solution for Molecular Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Comprehensive Solution for Molecular Testing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Comprehensive Solution for Molecular Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Comprehensive Solution for Molecular Testing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Comprehensive Solution for Molecular Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Nucleic Acid Amplification Testing
  • Protein Detection
  • Metabolite Detection
  • Others
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • Roche Diagnostics
  • Thermo Fisher Scientific
  • Qiagen
  • Illumina
  • Bio-Rad Laboratories
  • Cepheid
  • BD
  • GenMark Diagnostics
  • Hologic
  • PerkinElmer
  • Hanchenguangyi Technology
  • Shenzhen Guangyu Biotechnology
  • Hangzhou Leyi Biotechnology
  • Flashdx
  • VivaChek Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Comprehensive Solution for Molecular Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Comprehensive Solution for Molecular Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Comprehensive Solution for Molecular Testing Market Dynamics
  1. 2.1 Comprehensive Solution for Molecular Testing Industry Trends
  2. 2.2 Comprehensive Solution for Molecular Testing Industry Drivers
  3. 2.3 Comprehensive Solution for Molecular Testing Industry Opportunities and Challenges
  4. 2.4 Comprehensive Solution for Molecular Testing Industry Restraints
3 Comprehensive Solution for Molecular Testing Market by Company
  1. 3.1 Global Comprehensive Solution for Molecular Testing Company Revenue Ranking in 2025
  2. 3.2 Global Comprehensive Solution for Molecular Testing Revenue by Company (2021-2026)
  3. 3.3 Global Comprehensive Solution for Molecular Testing Company Ranking (2024-2026)
  4. 3.4 Global Comprehensive Solution for Molecular Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Comprehensive Solution for Molecular Testing Company Product Type and Application
  6. 3.6 Global Comprehensive Solution for Molecular Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Comprehensive Solution for Molecular Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Comprehensive Solution for Molecular Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Comprehensive Solution for Molecular Testing Market by Type
  1. 4.1 Comprehensive Solution for Molecular Testing Type Introduction
  2. 4.1.1 Nucleic Acid Amplification Testing
  3. 4.1.2 Protein Detection
  4. 4.1.3 Metabolite Detection
  5. 4.1.4 Others
  6. 4.2 Global Comprehensive Solution for Molecular Testing Sales Value by Type
  7. 4.2.1 Global Comprehensive Solution for Molecular Testing Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Comprehensive Solution for Molecular Testing Sales Value by Type (2021-2032)
  9. 4.2.3 Global Comprehensive Solution for Molecular Testing Sales Value Share by Type (2021-2032)
5 Comprehensive Solution for Molecular Testing Market by Application
  1. 5.1 Comprehensive Solution for Molecular Testing Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Research Institute
  4. 5.1.3 Others
  5. 5.2 Global Comprehensive Solution for Molecular Testing Sales Value by Application
  6. 5.2.1 Global Comprehensive Solution for Molecular Testing Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Comprehensive Solution for Molecular Testing Sales Value by Application (2021-2032)
  8. 5.2.3 Global Comprehensive Solution for Molecular Testing Sales Value Share by Application (2021-2032)
6 Comprehensive Solution for Molecular Testing Regional Value Analysis
  1. 6.1 Global Comprehensive Solution for Molecular Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Comprehensive Solution for Molecular Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Comprehensive Solution for Molecular Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Comprehensive Solution for Molecular Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Comprehensive Solution for Molecular Testing Sales Value (2021-2032)
  7. 6.3.2 North America Comprehensive Solution for Molecular Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Comprehensive Solution for Molecular Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Comprehensive Solution for Molecular Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Comprehensive Solution for Molecular Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Comprehensive Solution for Molecular Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Comprehensive Solution for Molecular Testing Sales Value (2021-2032)
  16. 6.6.2 South America Comprehensive Solution for Molecular Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Comprehensive Solution for Molecular Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Comprehensive Solution for Molecular Testing Sales Value Share by Country, 2025 VS 2032
7 Comprehensive Solution for Molecular Testing Country-level Value Analysis
  1. 7.1 Global Comprehensive Solution for Molecular Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Comprehensive Solution for Molecular Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Comprehensive Solution for Molecular Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Comprehensive Solution for Molecular Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Comprehensive Solution for Molecular Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Comprehensive Solution for Molecular Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Comprehensive Solution for Molecular Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche Diagnostics
  2. 8.1.1 Roche Diagnostics Company Information
  3. 8.1.2 Roche Diagnostics Business Overview
  4. 8.1.3 Roche Diagnostics Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Diagnostics Comprehensive Solution for Molecular Testing Product Portfolio
  6. 8.1.5 Roche Diagnostics Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Comprehensive Solution for Molecular Testing Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Qiagen
  14. 8.3.1 Qiagen Company Information
  15. 8.3.2 Qiagen Business Overview
  16. 8.3.3 Qiagen Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Qiagen Comprehensive Solution for Molecular Testing Product Portfolio
  18. 8.3.5 Qiagen Recent Developments
  19. 8.4 Illumina
  20. 8.4.1 Illumina Company Information
  21. 8.4.2 Illumina Business Overview
  22. 8.4.3 Illumina Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Illumina Comprehensive Solution for Molecular Testing Product Portfolio
  24. 8.4.5 Illumina Recent Developments
  25. 8.5 Bio-Rad Laboratories
  26. 8.5.1 Bio-Rad Laboratories Company Information
  27. 8.5.2 Bio-Rad Laboratories Business Overview
  28. 8.5.3 Bio-Rad Laboratories Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bio-Rad Laboratories Comprehensive Solution for Molecular Testing Product Portfolio
  30. 8.5.5 Bio-Rad Laboratories Recent Developments
  31. 8.6 Cepheid
  32. 8.6.1 Cepheid Company Information
  33. 8.6.2 Cepheid Business Overview
  34. 8.6.3 Cepheid Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cepheid Comprehensive Solution for Molecular Testing Product Portfolio
  36. 8.6.5 Cepheid Recent Developments
  37. 8.7 BD
  38. 8.7.1 BD Company Information
  39. 8.7.2 BD Business Overview
  40. 8.7.3 BD Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BD Comprehensive Solution for Molecular Testing Product Portfolio
  42. 8.7.5 BD Recent Developments
  43. 8.8 GenMark Diagnostics
  44. 8.8.1 GenMark Diagnostics Company Information
  45. 8.8.2 GenMark Diagnostics Business Overview
  46. 8.8.3 GenMark Diagnostics Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GenMark Diagnostics Comprehensive Solution for Molecular Testing Product Portfolio
  48. 8.8.5 GenMark Diagnostics Recent Developments
  49. 8.9 Hologic
  50. 8.9.1 Hologic Company Information
  51. 8.9.2 Hologic Business Overview
  52. 8.9.3 Hologic Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hologic Comprehensive Solution for Molecular Testing Product Portfolio
  54. 8.9.5 Hologic Recent Developments
  55. 8.10 PerkinElmer
  56. 8.10.1 PerkinElmer Company Information
  57. 8.10.2 PerkinElmer Business Overview
  58. 8.10.3 PerkinElmer Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PerkinElmer Comprehensive Solution for Molecular Testing Product Portfolio
  60. 8.10.5 PerkinElmer Recent Developments
  61. 8.11 Hanchenguangyi Technology
  62. 8.11.1 Hanchenguangyi Technology Company Information
  63. 8.11.2 Hanchenguangyi Technology Business Overview
  64. 8.11.3 Hanchenguangyi Technology Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hanchenguangyi Technology Comprehensive Solution for Molecular Testing Product Portfolio
  66. 8.11.5 Hanchenguangyi Technology Recent Developments
  67. 8.12 Shenzhen Guangyu Biotechnology
  68. 8.12.1 Shenzhen Guangyu Biotechnology Company Information
  69. 8.12.2 Shenzhen Guangyu Biotechnology Business Overview
  70. 8.12.3 Shenzhen Guangyu Biotechnology Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shenzhen Guangyu Biotechnology Comprehensive Solution for Molecular Testing Product Portfolio
  72. 8.12.5 Shenzhen Guangyu Biotechnology Recent Developments
  73. 8.13 Hangzhou Leyi Biotechnology
  74. 8.13.1 Hangzhou Leyi Biotechnology Company Information
  75. 8.13.2 Hangzhou Leyi Biotechnology Business Overview
  76. 8.13.3 Hangzhou Leyi Biotechnology Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hangzhou Leyi Biotechnology Comprehensive Solution for Molecular Testing Product Portfolio
  78. 8.13.5 Hangzhou Leyi Biotechnology Recent Developments
  79. 8.14 Flashdx
  80. 8.14.1 Flashdx Company Information
  81. 8.14.2 Flashdx Business Overview
  82. 8.14.3 Flashdx Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Flashdx Comprehensive Solution for Molecular Testing Product Portfolio
  84. 8.14.5 Flashdx Recent Developments
  85. 8.15 VivaChek Biotech
  86. 8.15.1 VivaChek Biotech Company Information
  87. 8.15.2 VivaChek Biotech Business Overview
  88. 8.15.3 VivaChek Biotech Comprehensive Solution for Molecular Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 VivaChek Biotech Comprehensive Solution for Molecular Testing Product Portfolio
  90. 8.15.5 VivaChek Biotech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst